[1]
Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol,2005,39: S138–S142.
DOI: 10.1097/01.mcg.0000155570.19340.61
Google Scholar
[2]
Zhang XJ, Katsuta Y, Akimoto T, et al. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol, 2003, 39: 724-730.
DOI: 10.1016/s0168-8278(03)00430-6
Google Scholar
[3]
Camille Taille,Jacques Cadranel,Agnes Bellocq,et al. Liver transplantation for hepatopulmonary syndrome: A ten-year experience in Paris. France. Transplantation, 2003, 79(5): 1482-1489.
DOI: 10.1097/01.tp.0000061612.78954.6c
Google Scholar
[4]
H. Kikuchi,N. Ohkohchi,T. Orii,et al. Living-related liver transplantation in patients with hepatopulmonary syndrome disease. Transplantation Proceedings, 2000, 32: 2177-2178.
DOI: 10.1016/s0041-1345(00)01623-7
Google Scholar
[5]
. Nunes H, Lebrec D, Mazmanian M, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001; 164: 879-85.
DOI: 10.1164/ajrccm.164.5.2009008
Google Scholar
[6]
. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26: 842-847.
DOI: 10.1053/jhep.1997.v26.pm0009328302
Google Scholar
[7]
Li X, Han DW, Zhao LF. Effect of glycine on the expression of peroxisome proliferators-activated receptor α in the rat nonalchoholic fatty liver. Zhongguo Binglishengli Zazhi, 2006, 22: 1829-1832.
Google Scholar
[8]
. Zhao LF, Huang T, Li H, Han DW. Therapeutic effect of glycine on chronic hepatic diseases. Shanxi Yikedaxue Zazhi, 2004, 35: 270-272.
Google Scholar
[9]
. Chen XH, Wang F, Han DW, et al. Mechanism and effects of glycine on endotoxin shock and endotoxin-induced hepatic injury. Zhonghua Shiyan Waike Zazhi, 2003, 20: 415-417.
Google Scholar
[10]
. Liu JC, Han DW, Xu RL, et al. Effect of glycine on the expression of CD14 gene and protein of hepatic tissue in the course of developing cirrhosis of rats. Zhonghua Ganzangbing Zazhi, 2002, 10: 181-184.
Google Scholar
[11]
Spittler A, Reissner CM, Oehler R, et al. Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression. FASEB J, 1999, 13: 563-571.
DOI: 10.1096/fasebj.13.3.563
Google Scholar
[12]
Bruck R , Wardi J, Aeed H, et al. Glycine modulates cytokine secretion, inhibits hepatic damage and improves survival in a model of endotoxemia in mice. Liver Int, 2003, 23: 276-282.
DOI: 10.1034/j.1600-0676.2003.00839.x
Google Scholar
[13]
Wheeler MD , Thurman RG. Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine. Am J Physiol, 1999, 277: L952-L959.
DOI: 10.1152/ajplung.1999.277.5.l952
Google Scholar
[14]
Alizadeh AH, Fatemi SR, Mirzaee V, et al. Clinical features of hepatopulmonary syndrome in cirrhotic patients. World J Gastroenterol, 2006, 12: 1954-(1956).
Google Scholar
[15]
Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med, 1998, 129: 375-378.
DOI: 10.7326/0003-4819-129-5-199809010-00005
Google Scholar
[16]
Zhang XJ, Katsuta Y, Akimoto T, et al. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol, 2003, 39: 724-730.
DOI: 10.1016/s0168-8278(03)00430-6
Google Scholar